2nd Annual Structure-Based Drug Design Summit

The 2nd Structure-Based Drug Design Summit is scheduled to take place from June 3 to 5, 2025, at the Revere Hotel Boston Common in Boston, Massachusetts. This premier event focuses on the latest advancements in integrative structural biology and computational tools aimed at accelerating early drug discovery. Attendees will delve into cutting-edge methodologies, including Cryo-EM, NMR, X-ray crystallography, and AI-driven modeling, to solve high-value targets and drive rational drug design across various modalities such as small molecules, peptides, biologics, and vaccines.

The summit will feature insights from leading experts in the field, including Alexey Rak, Head of Bio Structure and Biophysics at Sanofi; Ann Boriack-Sjodin, Executive Director & Global Head of Structural Biology at Takeda Pharmaceutical; and Dave Brown, Senior Director at Vertex Pharmaceuticals. Participants will have the opportunity to engage in expert-led discussions, case studies, and networking sessions, fostering collaborations and sharing best practices in structure-based drug design. The event also includes a poster session, allowing attendees to showcase and discuss their latest research in the field.